The first Parkinson’s disease patient has been implanted with Newronika‘s adaptive AlphaDBS, an innovative deep brain stimulation (DBS) system, as part of a pivotal clinical trial underway in Italy. The ADVENT study (NCT06891781) will compare the adaptive AlphaDBS system with conventional DBS in people with Parkinson’s. The trial…

Fall has a way of bringing back certain memories. Cooler weather (thank God, because it has been brutal!) makes me think about football, the changing leaves, and, unfortunately, dead deer. That last one is courtesy of Uncle Brandon. He loved deer hunting. Growing up in the Piney Woods of Texas,…

Blue light therapy delivered through Chrono Eyewear’s Propeaq glasses may help people with Parkinson’s disease sleep better and feel less sleepy during the day, a small study shows. After two weeks, those using blue light glasses reported greater improvements in sleep quality and daytime alertness, as well as…

Gain Therapeutics’ oral therapy candidate rexaceract, formerly called GT-02287, stabilized motor symptoms in a small group of people with Parkinson’s disease who were treated for one year. That’s according to new data from an open-label extension of an early clinical trial, which showed no meaningful progression of Parkinson’s…

I was very lucky to have a relationship with a truly remarkable neurologist for more than 12 years. I started seeing her right after I was diagnosed with early-onset Parkinson’s disease. The first time I met her, she told me, “You’re too young; you have too much to do.